Hinge Stuudio OÜ

Active Registry code 14459736 OÜ Tallinn Registered 29 Mar 2018
Compare

Hinge Stuudio OÜ is a OÜ based in Tallinn, registry code 14459736, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €2 130 and 0 employees.

Revenue
2 130 €
↓ 28.5% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 2 130 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 5.8 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2018 – 2025
Revenue, € 2025: 2 130 € · −28.5% vs 2024 · industry median 20 811 € · above 27% of the industry
010 00020 00030 0002018 Company: — Industry median: —20182019 Company: 981 € Industry median: 25 166 €20192020 Company: 1 950 € Industry median: 20 220 €20202021 Company: 2 630 € Industry median: 20 121 €20212022 Company: 5 572 € Industry median: 20 030 €20222023 Company: 3 947 € Industry median: 19 469 €20232024 Company: 2 980 € Industry median: 20 000 €20242025 Company: 2 130 € Industry median: 20 811 €2025010 00020 00030 0002018 Company: — Industry median: —2019 Company: 981 € Industry median: 25 166 €20192020 Company: 1 950 € Industry median: 20 220 €2021 Company: 2 630 € Industry median: 20 121 €20212022 Company: 5 572 € Industry median: 20 030 €2023 Company: 3 947 € Industry median: 19 469 €20232024 Company: 2 980 € Industry median: 20 000 €2025 Company: 2 130 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 123 € · −72.8% vs 2024 · industry median 1 071 € · above 40% of the industry
01 0002 0003 0002018 Company: — Industry median: —20182019 Company: 2 861 € Industry median: 2 596 €20192020 Company: 2 120 € Industry median: 2 208 €20202021 Company: 737 € Industry median: 1 834 €20212022 Company: 1 978 € Industry median: 1 525 €20222023 Company: 262 € Industry median: 1 745 €20232024 Company: 453 € Industry median: 1 621 €20242025 Company: 123 € Industry median: 1 071 €202501 0002 0003 0002018 Company: — Industry median: —2019 Company: 2 861 € Industry median: 2 596 €20192020 Company: 2 120 € Industry median: 2 208 €2021 Company: 737 € Industry median: 1 834 €20212022 Company: 1 978 € Industry median: 1 525 €2023 Company: 262 € Industry median: 1 745 €20232024 Company: 453 € Industry median: 1 621 €2025 Company: 123 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 5.8 % · −9.4 pp vs the year before · industry median 8.3 % · above 44% of the industry
02550751001252018 Company: — Industry median: —20182019 Company: — Industry median: 10.3 %20192020 Company: 108.7 % Industry median: 12.4 %20202021 Company: 28.0 % Industry median: 13.0 %20212022 Company: 35.5 % Industry median: 11.3 %20222023 Company: 6.6 % Industry median: 11.4 %20232024 Company: 15.2 % Industry median: 10.7 %20242025 Company: 5.8 % Industry median: 8.3 %202502550751001252018 Company: — Industry median: —2019 Company: — Industry median: 10.3 %20192020 Company: 108.7 % Industry median: 12.4 %2021 Company: 28.0 % Industry median: 13.0 %20212022 Company: 35.5 % Industry median: 11.3 %2023 Company: 6.6 % Industry median: 11.4 %20232024 Company: 15.2 % Industry median: 10.7 %2025 Company: 5.8 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 3 970 € · +1.6% vs 2024
01 0002 0003 0004 0002018 Company: —20182019 Company: 108 €20192020 Company: 457 €20202021 Company: 1 204 €20212022 Company: 3 231 €20222023 Company: 3 473 €20232024 Company: 3 908 €20242025 Company: 3 970 €202501 0002 0003 0004 0002018 Company: —2019 Company: 108 €20192020 Company: 457 €2021 Company: 1 204 €20212022 Company: 3 231 €2023 Company: 3 473 €20232024 Company: 3 908 €2025 Company: 3 970 €2025
Equity, € 2025: 3 970 € · +3.2% vs 2024
-2 00002 0004 0002018 Company: —20182019 Company: -1 703 €20192020 Company: 417 €20202021 Company: 1 154 €20212022 Company: 3 132 €20222023 Company: 3 393 €20232024 Company: 3 847 €20242025 Company: 3 970 €2025-2 00002 0004 0002018 Company: —2019 Company: -1 703 €20192020 Company: 417 €2021 Company: 1 154 €20212022 Company: 3 132 €2023 Company: 3 393 €20232024 Company: 3 847 €2025 Company: 3 970 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
01232018 Company: 0 Industry median: 320182019 Company: 0 Industry median: 320192020 Company: 0 Industry median: 320202021 Company: 0 Industry median: 2.520212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 2202501232018 Company: 0 Industry median: 32019 Company: 0 Industry median: 320192020 Company: 0 Industry median: 32021 Company: 0 Industry median: 2.520212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 2 130 123 0 3 970 3 970 0
2024 2 980 453 0 3 908 3 847 0
2023 3 947 262 0 3 473 3 393 0
2022 5 572 1 978 0 3 231 3 132 0
2021 2 630 737 0 1 204 1 154 0
2020 1 950 2 120 0 457 417 0
2019 981 2 861 0 108 -1 703 0
2018 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
5.8 %
Net profit / revenue
Return on equity (ROE)
3.1 %
Net profit / equity
Return on assets (ROA)
3.1 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 15 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 22 May 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 3 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 12 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 3 Mar 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 9 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 7 Jun 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 86992Other human health activities n.e.c. Main

Rulings 5

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50091026 / 5
5 May 2025
 Amendment under Code of Civil Procedure § 595¹ (1) In force
5 May 2025
 PDF
Ä 50091026 / 4
22 Sep 2024
 Amendment entry In force
22 Sep 2024
 PDF
Ä 50091026 / 3
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50091026 / 2
3 Mar 2020
 Amendment under Commercial Code § 525 (2) In force
3 Mar 2020
 PDF
Ä 50091026
29 Mar 2018
 First entry In force
29 Mar 2018
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data